Mychal James Bradley Gibbens

Array ( [id] => 11663567 [patent_doc_number] => 20170152286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-01 [patent_title] => 'STAPLED HELICAL PEPTIDES AND METHODS OF SYNTHESIS' [patent_app_type] => utility [patent_app_number] => 15/363626 [patent_app_country] => US [patent_app_date] => 2016-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15011 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15363626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15395821 [patent_doc_number] => 10538554 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-21 [patent_title] => Peptides and uses therefor as antiviral agents [patent_app_type] => utility [patent_app_number] => 15/778822 [patent_app_country] => US [patent_app_date] => 2016-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 17000 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17586554 [patent_doc_number] => 11324796 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-10 [patent_title] => Method for regulating lipolysis and fatty acid oxidative metabolism [patent_app_type] => utility [patent_app_number] => 16/311221 [patent_app_country] => US [patent_app_date] => 2016-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 24 [patent_no_of_words] => 8652 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11995449 [patent_doc_number] => 20170299604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'SRM METHODS IN ALZHEIMER\'S DISEASE AND NEUROLOGICAL DISEASE ASSAYS' [patent_app_type] => utility [patent_app_number] => 15/355213 [patent_app_country] => US [patent_app_date] => 2016-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29149 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15355213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11471490 [patent_doc_number] => 20170058273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-02 [patent_title] => 'N-terminal Derivatisation of Proteins with Polysaccharides' [patent_app_type] => utility [patent_app_number] => 15/352466 [patent_app_country] => US [patent_app_date] => 2016-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 10389 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15352466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11491503 [patent_doc_number] => 20170065688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-09 [patent_title] => 'COMPOSITIONS CONTAINING ALPHA-1-ANTITRYPSIN AND METHODS FOR USE' [patent_app_type] => utility [patent_app_number] => 15/352375 [patent_app_country] => US [patent_app_date] => 2016-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18024 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15352375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11499183 [patent_doc_number] => 20170073369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-16 [patent_title] => 'METHODS FOR THE TREATMENT OF X-LINKED HYPOPHOSPHATEMIA AND RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 15/346522 [patent_app_country] => US [patent_app_date] => 2016-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13357 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15346522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12526941 [patent_doc_number] => 10005823 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-26 [patent_title] => Peptides having effects on promoting wound healing, collagen production, angiogenesis, activation of immunocytes and applications thereof [patent_app_type] => utility [patent_app_number] => 15/336212 [patent_app_country] => US [patent_app_date] => 2016-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 2954 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15336212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13867567 [patent_doc_number] => 20190030124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-31 [patent_title] => USE OF DERMCIDIN IN STERILE INFLAMMATORY CONDITIONS [patent_app_type] => utility [patent_app_number] => 15/769880 [patent_app_country] => US [patent_app_date] => 2016-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5541 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15769880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13276643 [patent_doc_number] => 10149887 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-12-11 [patent_title] => Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting agents for cancer treatment [patent_app_type] => utility [patent_app_number] => 15/331478 [patent_app_country] => US [patent_app_date] => 2016-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 39 [patent_no_of_words] => 31667 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15331478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11435978 [patent_doc_number] => 20170036999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-09 [patent_title] => 'IMMUNOSTIMULATING AGENT' [patent_app_type] => utility [patent_app_number] => 15/331094 [patent_app_country] => US [patent_app_date] => 2016-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 22099 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15331094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12965050 [patent_doc_number] => 09874570 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-23 [patent_title] => Method of detecting at least one mechanism of resistance to cephalosporins by mass spectrometry [patent_app_type] => utility [patent_app_number] => 15/295061 [patent_app_country] => US [patent_app_date] => 2016-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 115499 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15295061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11443194 [patent_doc_number] => 20170044214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-16 [patent_title] => 'SELECTIVE DELIVERY MOLECULES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 15/295482 [patent_app_country] => US [patent_app_date] => 2016-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 55698 [patent_no_of_claims] => 238 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15295482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15385655 [patent_doc_number] => 10534005 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-14 [patent_title] => Method for the in vitro diagnosis of thyroid diseases [patent_app_type] => utility [patent_app_number] => 15/768626 [patent_app_country] => US [patent_app_date] => 2016-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2434 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15768626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13577319 [patent_doc_number] => 20180340208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-29 [patent_title] => COMPOSITIONS AND METHODS FOR ABSOLUTE QUANTIFICATION OF PROTEINS [patent_app_type] => utility [patent_app_number] => 15/768421 [patent_app_country] => US [patent_app_date] => 2016-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12500 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15768421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11894084 [patent_doc_number] => 09764004 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-19 [patent_title] => 'Glucagon receptor agonists' [patent_app_type] => utility [patent_app_number] => 15/293324 [patent_app_country] => US [patent_app_date] => 2016-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18011 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15293324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13024531 [patent_doc_number] => 10034877 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-31 [patent_title] => Treatment for diabetes in patients inappropriate for metformin therapy [patent_app_type] => utility [patent_app_number] => 15/287228 [patent_app_country] => US [patent_app_date] => 2016-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11025 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15287228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13011689 [patent_doc_number] => 10028945 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-24 [patent_title] => Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof [patent_app_type] => utility [patent_app_number] => 15/285818 [patent_app_country] => US [patent_app_date] => 2016-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 20 [patent_no_of_words] => 48658 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 561 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15285818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13493033 [patent_doc_number] => 20180298059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-18 [patent_title] => A NEW TYPE POLYPEPTIDE TARGETING TUMOURS [patent_app_type] => utility [patent_app_number] => 15/767146 [patent_app_country] => US [patent_app_date] => 2016-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6722 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15767146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13490309 [patent_doc_number] => 20180296697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-18 [patent_title] => ENZYME-RESPONSIVE PEPTIDE NANOFIBER COMPOSITIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/764188 [patent_app_country] => US [patent_app_date] => 2016-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19950 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15764188 [rel_patent_id] =>[rel_patent_doc_number] =>)